Cocrystal Pharma, Inc. announced that it expects to receive $4.000002 million in funding from Frost Gamma Investments Trust and other investor

Cocrystal Pharma, Inc. announced a securities purchase agreement of 2,030,458 shares of common stock at a price of $1.97 per share for a gross proceeds of $4,000,000 on April 4, 2023. The transaction will include participation from Fred Hassan and new investor, Frost Gamma Investments Trust. The company will raise two equal investments of $2,000,000 each from the investors.